Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Venus Concept ( (VERO) ).
On October 31, 2025, Venus Concept Inc. and its subsidiaries entered into a Consent Agreement with Madryn Health Partners, providing relief under a prior loan agreement by waiving certain liquidity requirements and allowing interest payments to be applied to the principal balance. Additionally, they amended a bridge loan agreement to extend its maturity date and waive liquidity requirements until November 30, 2025. The company also completed a Thirteenth Delayed Drawdown on October 28, 2025, securing $2,000,000 for general working capital purposes.
The most recent analyst rating on (VERO) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Venus Concept stock, see the VERO Stock Forecast page.
Spark’s Take on VERO Stock
According to Spark, TipRanks’ AI Analyst, VERO is a Neutral.
Venus Concept’s overall stock score is primarily impacted by its poor financial performance, characterized by high leverage, declining revenues, and substantial losses. Technical analysis and valuation further reflect bearish sentiment and lack of profitability. While the earnings call highlights some strategic improvements, significant challenges remain, limiting the overall score.
To see Spark’s full report on VERO stock, click here.
More about Venus Concept
Average Trading Volume: 86,384
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.92M
For detailed information about VERO stock, go to TipRanks’ Stock Analysis page.